Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders

Behav Pharmacol. 2000 Jun;11(3-4):235-42. doi: 10.1097/00008877-200006000-00007.

Abstract

Neurotrophic factors, such as nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), are known to play a crucial role in growth, differentiation and function in a variety of brain neurons during development and in adult life. We have recently shown that environmental changes, aggressive behavior and anxiety-like responses alter both circulating and brain basal NGF levels. In the present review, we present data obtained using animal models which suggest that neurotrophic factors, particularly NGF and BDNF, might be implicated in mechanism(s) leading to a condition associated with schizophrenic-like behaviors. The hypothesis that neurotrophins of the NGF family can be implicated in some maldevelopmental aspects of schizophrenia is supported by findings indicating that the constitutive levels of NGF and BDNF are affected in schizophrenic patients.

Publication types

  • Review

MeSH terms

  • Aggression
  • Animals
  • Anxiety / drug therapy
  • Brain / growth & development
  • Brain / pathology
  • Brain-Derived Neurotrophic Factor / pharmacology*
  • Central Nervous System Depressants / adverse effects
  • Disease Models, Animal
  • Ethanol / adverse effects
  • Humans
  • Nerve Growth Factor / pharmacology*
  • Rats
  • Schizophrenia / physiopathology*

Substances

  • Brain-Derived Neurotrophic Factor
  • Central Nervous System Depressants
  • Ethanol
  • Nerve Growth Factor